Vimarsana
Biggest News Aggregation in the World

Page 27 - Ace2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ace2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ace2 Today - Breaking & Trending Today

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility - Vimarsana News

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

An interesting new study deals with the effects of the natural mutations in the spike antigen of the SARS-CoV-2, the pathogen that is responsible for the ongoing coronavirus disease pandemic.

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells - Vimarsana News

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells

Cannabis compound inhibits SARS-CoV-2 replication in human lung cells Researchers in the United States have conducted a study showing that a cannabis plant compound inhibited infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human lung cells. SARS-CoV-2 is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that continues to sweep the globe posing a threat to global public health and the worldwide economy. Marsha Rosner from the University of Chicago in Illinois and colleagues found that cannabidiol (CBD) and its metabolite 7-OH-CBD potently...

White-tailed deer susceptible to SARS-CoV-2, finds study - Vimarsana News

White-tailed deer susceptible to SARS-CoV-2, finds study

White-tailed deer susceptible to SARS-CoV-2, finds study White-tailed deer have been observed to be susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They can also transmit the virus both through direct and indirect contact to one another, researchers find. The research paper is available to be read online in the The origins of SARS-CoV-2, the underlying causative agent for coronavirus disease 2019 (COVID-19), are still unknown. Genome sequencing of the virus has so far provided evidence of an origination event in horseshoe bats. However, as no evidence can be foun...

APEIRON's APN01 shows clinical benefits for severely ill COVID-19 patients in phase 2 trial - Vimarsana News

APEIRON's APN01 shows clinical benefits for severely ill COVID-19 patients in phase 2 trial

12.03.2021 APEIRON's APN01 shows clinical benefits for severely ill COVID-19 patients in phase 2 trial | ACE2 | APN01 | COVID |

Source: dgap.de
Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization - Vimarsana News

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Researchers based in Beijing and Shenzhen, China, report that they have identified mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may allow variant strains to avoid neutralization by monoclonal antibodies and convalescent blood plasma.